UTHR(United Therapeutics Corporation) 的内部人交易:医疗保健,特药与仿制药。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 交易日 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-11-19 | MAHON PAUL A | EVP & GENERAL COUNSEL | 公开市场卖出 | 114 | $577.19 |
| 2026-11-19 | MAHON PAUL A | EVP & GENERAL COUNSEL | 公开市场卖出 | 134 | $575.93 |
| 2026-11-19 | MAHON PAUL A | EVP & GENERAL COUNSEL | 公开市场卖出 | 192 | $574.75 |
| 2026-11-19 | MAHON PAUL A | EVP & GENERAL COUNSEL | 公开市场卖出 | 561 | $573.79 |
| 2026-11-19 | MAHON PAUL A | EVP & GENERAL COUNSEL | 公开市场卖出 | 601 | $572.70 |
| 2026-11-19 | MAHON PAUL A | EVP & GENERAL COUNSEL | 公开市场卖出 | 464 | $571.79 |
| 2026-11-19 | MAHON PAUL A | EVP & GENERAL COUNSEL | 公开市场卖出 | 756 | $570.73 |
| 2026-11-19 | MAHON PAUL A | EVP & GENERAL COUNSEL | 公开市场卖出 | 700 | $569.68 |
| 2026-11-19 | MAHON PAUL A | EVP & GENERAL COUNSEL | 公开市场卖出 | 300 | $568.62 |
| 2026-11-19 | MAHON PAUL A | EVP & GENERAL COUNSEL | 公开市场卖出 | 200 | $566.91 |
| 2026-11-19 | MAHON PAUL A | EVP & GENERAL COUNSEL | 公开市场卖出 | 655 | $565.62 |
| 2026-11-19 | MAHON PAUL A | EVP & GENERAL COUNSEL | 公开市场卖出 | 69 | $564.44 |
| 2026-11-19 | MAHON PAUL A | EVP & GENERAL COUNSEL | 公开市场卖出 | 76 | $563.22 |
| 2026-11-19 | MAHON PAUL A | EVP & GENERAL COUNSEL | 公开市场卖出 | 300 | $561.78 |
| 2026-11-19 | MAHON PAUL A | EVP & GENERAL COUNSEL | 公开市场卖出 | 197 | $560.63 |
| 2026-11-19 | MAHON PAUL A | EVP & GENERAL COUNSEL | 公开市场卖出 | 400 | $559.50 |
| 2026-11-19 | MAHON PAUL A | EVP & GENERAL COUNSEL | 公开市场卖出 | 378 | $558.49 |
| 2026-11-19 | MAHON PAUL A | EVP & GENERAL COUNSEL | 公开市场卖出 | 523 | $557.46 |
| 2026-11-19 | MAHON PAUL A | EVP & GENERAL COUNSEL | 公开市场卖出 | 1,240 | $556.07 |
| 2026-11-19 | MAHON PAUL A | EVP & GENERAL COUNSEL | 公开市场卖出 | 440 | $554.73 |